TGFαPE38 enhances cytotoxic Tlymphocyte killing of breast cancer cells

By                

Oncology Letters, Vol. 7, Iss. 6, 2014-01 ,pp. : 2113-2117

Spandidos Publications

Access to resources Recommend Favorite

Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine

By                    

Oncology Reports, Vol. 34, Iss. 1, 2015-01 ,pp. : 504-510

Spandidos Publications

Access to resources Recommend Favorite

Cytotoxicity of Cord Blood Derived Her2/ neu -specific Cytotoxic T Lymphocytes against Human Breast Cancer in vitro and in vivo

By Wang Peng   Munger Corey M.   Joshi Avadhut D.   Pirruccello Samuel J.   Joshi Shantaram S.  

Breast Cancer Research and Treatment, Vol. 83, Iss. 1, 2004-01 ,pp. : 15-23

Springer Publishing Company

Access to resources Recommend Favorite

Langerhans cells and dendritic cells are cytotoxic towards HPV16 E6 and E7 expressing target cells

By Poole I.   ElMasri Wafic   Denman Cecele   Kroll Tara   Bommiasamy Hemamalini   Lyons Eiben Gretchen   Kast W.  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 6, 2008-06 ,pp. : 789-797

Springer Publishing Company

Access to resources Recommend Favorite

Cytotoxic and radiosensitizing effects of FAK targeting in human glioblastoma cells in vitro

By      

Oncology Reports, Vol. 33, Iss. 4, 2015-01 ,pp. : 2009-2016

Spandidos Publications

Access to resources Recommend Favorite